OKYO Pharma Ltd

Ownership Transactions Reported by 6 Insiders

Symbol
OKYO on Nasdaq
Location
55 Park Lane, London, United Kingdom

There are no Buy or Sell transactions made by insiders since 10/2/2023

OKYO Pharma Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gabriele M. Cerrone Executive Chairman, Director $13.8M Oct 23, 2023
Gary Jacob Chief Executive Officer, Director $50K May 19, 2022
John Brancaccio Director $25K Sep 15, 2023
Keeren Shah Chief Financial Officer May 16, 2022
Willy Jules Simon Director May 16, 2022
Bernard Denoyer Director May 16, 2022

Recent Insider Transactions by Companies or Individuals for OKYO Pharma Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.